ClinicalTrials.Veeva

Menu

Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder

F

Federal University of Minas Gerais

Status and phase

Completed
Phase 4

Conditions

Menopause
Sexual Abstinence

Treatments

Drug: Tribulus Terrestris
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01975649
TTC
245.553C (Other Identifier)

Details and patient eligibility

About

Hypoactive Sexual Desire Disorder ( HSDD ) is very common in postmenopausal women due to a reduction in circulating androgen levels. The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD.

Full description

Hypoactive Sexual Desire Disorder ( HSDD ) is the most prevalent female sexual dysfunction in society mainly in postmenopausal women, and is strongly linked to the quality of life of women . The androgen hormones decline over age in the premenopausal period, more sharply after menopause. Tribulus terrestris is a plant native to India , recommended in the treatment of infertility , low libido and impotence . Its main active ingredient is the protodioscin , which has been attributed to an increase in testosterone levels and improved sexual function . The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD .

Enrollment

44 patients

Sex

Female

Ages

50 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • at least one year after last menstrual period
  • with no use of hormonal replacement therapy within the last 3 months
  • without any medication, drugs or alcohol.
  • Healthy patients without systemic or psychiatric disease

Exclusion criteria

  • Patient smoker (10 cigarettes per day).
  • Patients with blood pressure > 160/90 mm Hg.
  • Patient with breast or endometrial carcinoma.
  • Patients with a history of myocardial infarction.
  • Patient with Diabetes.
  • Patient with vaginal bleeding from any source.
  • Patients with hepatic injury.
  • Patients with active thrombophlebitis or thromboembolic disorders recent
  • Patients with interpersonal relationship problems with your relationship or partner
  • Patients with sexual problems from your partner

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

44 participants in 2 patient groups, including a placebo group

Tribulus Terrestris
Experimental group
Description:
patients will use Tribulus terrestris (750 mg/day) during 120 days
Treatment:
Drug: Tribulus Terrestris
Placebo
Placebo Comparator group
Description:
patients will use placebo for 120 days
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems